Real-time enrollment status for this lymphoma diffuse large b-cell clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 10:29 PM UTC
| NCT Number | NCT07284433 |
| Recruiting Status | Recruiting |
| Condition | Lymphoma Diffuse Large B-cell |
| Phase | PHASE1 |
| Target Enrollment | 178 participants |
| Active Locations | 5 sites in the US |
| Sponsor | AvenCell Therapeutics, Inc. |
| Last Updated on CT.gov | August 28, 2026 (6 days ago) |
As of September 3, 2026: Clinical trial NCT07284433 is currently recruiting participants. This phase1 study for lymphoma diffuse large b-cell is actively seeking new participants at 5 locations across the United States. The study is sponsored by AvenCell Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07284433 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07284433 was last updated 6 days ago (August 28, 2026). HelloStudys verifies this status automatically.